Cargando…
Azacytidine and Venetoclax in Relapsed and Refractory Patients With Angioimmunoblastic T-cell Lymphoma
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812600/ https://www.ncbi.nlm.nih.gov/pubmed/35141469 http://dx.doi.org/10.1097/HS9.0000000000000675 |
_version_ | 1784644689011408896 |
---|---|
author | Laribi, Kamel Baugier de Materre, Alix Touileb, Yamina Boursot, Charles Sandrini, Jeremy Cavalieri, Doriane Pastoret, Cédric de Leval, Laurence Tournilhac, Olivier |
author_facet | Laribi, Kamel Baugier de Materre, Alix Touileb, Yamina Boursot, Charles Sandrini, Jeremy Cavalieri, Doriane Pastoret, Cédric de Leval, Laurence Tournilhac, Olivier |
author_sort | Laribi, Kamel |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8812600 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-88126002022-02-08 Azacytidine and Venetoclax in Relapsed and Refractory Patients With Angioimmunoblastic T-cell Lymphoma Laribi, Kamel Baugier de Materre, Alix Touileb, Yamina Boursot, Charles Sandrini, Jeremy Cavalieri, Doriane Pastoret, Cédric de Leval, Laurence Tournilhac, Olivier Hemasphere Case Report Lippincott Williams & Wilkins 2022-02-01 /pmc/articles/PMC8812600/ /pubmed/35141469 http://dx.doi.org/10.1097/HS9.0000000000000675 Text en Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Laribi, Kamel Baugier de Materre, Alix Touileb, Yamina Boursot, Charles Sandrini, Jeremy Cavalieri, Doriane Pastoret, Cédric de Leval, Laurence Tournilhac, Olivier Azacytidine and Venetoclax in Relapsed and Refractory Patients With Angioimmunoblastic T-cell Lymphoma |
title | Azacytidine and Venetoclax in Relapsed and Refractory Patients With Angioimmunoblastic T-cell Lymphoma |
title_full | Azacytidine and Venetoclax in Relapsed and Refractory Patients With Angioimmunoblastic T-cell Lymphoma |
title_fullStr | Azacytidine and Venetoclax in Relapsed and Refractory Patients With Angioimmunoblastic T-cell Lymphoma |
title_full_unstemmed | Azacytidine and Venetoclax in Relapsed and Refractory Patients With Angioimmunoblastic T-cell Lymphoma |
title_short | Azacytidine and Venetoclax in Relapsed and Refractory Patients With Angioimmunoblastic T-cell Lymphoma |
title_sort | azacytidine and venetoclax in relapsed and refractory patients with angioimmunoblastic t-cell lymphoma |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812600/ https://www.ncbi.nlm.nih.gov/pubmed/35141469 http://dx.doi.org/10.1097/HS9.0000000000000675 |
work_keys_str_mv | AT laribikamel azacytidineandvenetoclaxinrelapsedandrefractorypatientswithangioimmunoblastictcelllymphoma AT baugierdematerrealix azacytidineandvenetoclaxinrelapsedandrefractorypatientswithangioimmunoblastictcelllymphoma AT touilebyamina azacytidineandvenetoclaxinrelapsedandrefractorypatientswithangioimmunoblastictcelllymphoma AT boursotcharles azacytidineandvenetoclaxinrelapsedandrefractorypatientswithangioimmunoblastictcelllymphoma AT sandrinijeremy azacytidineandvenetoclaxinrelapsedandrefractorypatientswithangioimmunoblastictcelllymphoma AT cavalieridoriane azacytidineandvenetoclaxinrelapsedandrefractorypatientswithangioimmunoblastictcelllymphoma AT pastoretcedric azacytidineandvenetoclaxinrelapsedandrefractorypatientswithangioimmunoblastictcelllymphoma AT delevallaurence azacytidineandvenetoclaxinrelapsedandrefractorypatientswithangioimmunoblastictcelllymphoma AT tournilhacolivier azacytidineandvenetoclaxinrelapsedandrefractorypatientswithangioimmunoblastictcelllymphoma |